Evidence map›Paper›PMID 31647823›Full record

ArticlePloS one2019

Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.

Seung Joon Lee, Tae Seok Sim, Hyun Young Shin, Jungmin Lee, Min Young Kim, Joseph Sunoo, Jeong-Gun Lee, Kyungmoo Yea, Young Zoon Kim, Danny van Noort and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Seung Joon LeeDepartment of New Biology, DGIST, Daegu, Republic of Korea.
Tae Seok SimSamsung Electronics, Ltd., Maetan3-dong, Youngtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea.
Hyun Young ShinDepartment of New Biology, DGIST, Daegu, Republic of Korea.
Jungmin LeeDepartment of New Biology, DGIST, Daegu, Republic of Korea.
Min Young KimDepartment of New Biology, DGIST, Daegu, Republic of Korea.
Joseph SunooCytoDx, Pangyo-ro, Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea.
Jeong-Gun LeeSamsung Electronics, Ltd., Maetan3-dong, Youngtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea.
Kyungmoo YeaDepartment of New Biology, DGIST, Daegu, Republic of Korea.
Young Zoon KimDivision of Neurooncology and Department of Neurosurgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
Danny van NoortDepartment of New Biology, DGIST, Daegu, Republic of Korea.
Soo Kyung ParkCytoDx, Pangyo-ro, Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea.
Woon-Hae KimDepartment of New Biology, DGIST, Daegu, Republic of Korea.ORCID 0000-0002-1536-5374
Kyun Woo ParkDaejeon Wellness Hospital, Beon-gil, Dongseo-daero, Daedeok-gu, Daejeon, Republic of Korea.
Minseok S KimDepartment of New Biology, DGIST, Daegu, Republic of Korea.ORCID 0000-0002-4268-6886
Daegu Gyeongbuk Institute of Science and Technology · KRLinköping University · SESamsung (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microchips are widely used to separate circulating tumor cells (CTCs) from whole blood by virtues of sophisticated manipulation for microparticles. Here, we present a chip with an 8 μm high and 27.9 mm wide slit to capture cancer cells bound to 3 μm beads. Apart from a higher purity and recovery rate, the slit design allows for simplified fabrication, easy cell imaging, less clogging, lower chamber pressure and, therefore, higher throughput. The beads were conjugated with anti-epithelial cell adhesion molecules (anti-EpCAM) to selectively bind to breast cancer cells (MCF-7) used to spike the whole blood. The diameter of the cell-bead construct was in average 23.1 μm, making them separable from other cells in the blood. As a result, the cancer cells were separated from 5 mL of whole blood with a purity of 52.0% and a recovery rate of 91.1%, and also we confirmed that the device can be applicable to clinical samples of human breast cancer patients. The simple design with microslit, by eliminating any high-aspect ratio features, is expected to reduce possible defects on the chip and, therefore, more suitable for mass production without false separation outputs.

Indexed as

Microfluidic Analytical TechniquesNeoplastic Cells, CirculatingAntigens, NeoplasmBreast NeoplasmsFemaleHumansMCF-7 CellsMicrospheresPrecancerous ConditionsAntigens, Neoplasm

Identifiers

PMID31647823
PMCPMC6812780
OpenAlexW2981775478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.